Pragmatic Cluster Trial for Nursing Home Antipsychotic Prescribing
NCT02604056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2018-03-23
Summary
Two arm, pragmatic, cluster-randomized trial, with nursing homes allocated to the full, active intervention (featuring educational outreach offered to each prescriber and team members in the home) or standard quality improvement supports (including online audit and feedback reports for each prescriber in the home). The 'standard' quality improvement supports represent 'usual care' as these are to be launched province-wide; a concurrent control arm with no exposure to a quality improvement intervention is not feasible.
Conditions
- Adverse Effect of Other Antipsychotics and Neuroleptics
Interventions
- BEHAVIORAL
-
Audit + Feedback
Online Audit + Feedback practice reports detailing prescribing performance for this class of medication for each prescriber in the nursing home. (Details: http://www.hqontario.ca/Quality-Improvement/Practice-Reports/Primary-Care)
- BEHAVIORAL
-
Audit + Feedback + Educational Outreach
The Educational Outreach program will be delivered by academic detailers, health professionals (often nurses or pharmacists) who have received specific intensive training to support prescribing providers in a particular environment, in this case long-term care homes, to make the best or appropriate clinical decisions as possible. It is defined as: "an innovative method of service-oriented educational outreach for front-line clinicians. It combines the interactive, one-on-one communication approach of industry detailers with the evidence-based, non-commercial information of academia." The Educational Outreach will be delivered in addition to online Audit + Feedback practice reports, which detail prescribing performance for this class of medication for each prescriber in the nursing home.
Sponsors & Collaborators
-
Ontario Ministry of Health and Long Term Care
collaborator OTHER_GOV -
Ontario Medical Association
collaborator OTHER -
Health Quality Ontario
collaborator OTHER -
Centre for Effective Practice
collaborator OTHER -
Women's College Hospital
lead OTHER
Principal Investigators
-
Noah Ivers · Family Doctor and Research Scientist
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2017-04-30
- Completion
- 2017-04-30
More Related Trials
-
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Effectiveness of Cognitive Adaptation Training in Early Intervention for Psychosis
NCT02430935 ·Status: COMPLETED ·Phase: NA
-
Group Psychoeducation to Promote Independent Living in Individuals With Psychiatric Disorders
NCT07317388 ·Status: RECRUITING
-
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718 ·Status: COMPLETED ·Phase: NA
-
Study of Pharmacotherapy of Psychotic Depression
NCT00056472 ·Status: COMPLETED ·Phase: PHASE3
-
Antipsychotic Polypharmacy: Prevalence, Background and Consequences
NCT00541398 ·Status: COMPLETED ·Phase: NA
-
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness
NCT00057135 ·Status: COMPLETED ·Phase: NA
-
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
NCT00204061 ·Status: COMPLETED ·Phase: PHASE4
-
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529 ·Status: COMPLETED ·Phase: PHASE4
-
Contrasting Group Therapy Methods for Psychosis
NCT01764568 ·Status: TERMINATED ·Phase: NA
-
Effectiveness of Anti-Psychotic in GPs Setting
NCT00543088 ·Status: COMPLETED
-
Comparing Antipsychotic Medications in LBD Over Time
NCT05590637 ·Status: RECRUITING ·Phase: PHASE4
-
Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales
NCT06238089 ·Status: RECRUITING
-
Cognition, Functioning and Quality of Life
NCT00182442 ·Status: COMPLETED ·Phase: PHASE4
-
Promoting Cognitive Health in Schizophrenia
NCT05661448 ·Status: RECRUITING ·Phase: NA
-
Patient-Centered Medication Adherence Intervention for Schizophrenia
NCT00144027 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893 ·Status: COMPLETED
-
Treatment of Psychosis and Agitation in Alzheimer's Disease
NCT02129348 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
NCT07056894 ·Status: RECRUITING ·Phase: NA
-
Non-Pharmacological Treatment of Psychosis
NCT04051775 ·Status: UNKNOWN
-
Virtual Cognitive Behavioural Therapy for Psychosis
NCT04752449 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms
NCT02529163 ·Status: UNKNOWN ·Phase: NA
-
Medication Adherence in Older People With Psychosis
NCT00071604 ·Status: UNKNOWN ·Phase: NA
-
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
NCT01164059 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia
NCT03695614 ·Status: COMPLETED ·Phase: NA